Greenyn Biotechnology Co., Ltd.(TW:6846)
NT$49.000.00 (0.00%)
TW:6846
Greenyn Biotechnology Co., Ltd. Revenue
NT$49.00
At close:0.00 (0.00%)
Greenyn Biotechnology Co., Ltd. (6846) Revenue
Greenyn Biotechnology Co., Ltd. Revenue
Greenyn Biotechnology Co., Ltd. had a revenue of 195.76M in the quarter ending Jun 30, 2026, with -1.18%. This bring the company's revenue in the last twelve months to 867.63M, Decreased 1.48%. In the fiscal year ending Dec 31, 2025, Greenyn Biotechnology Co., Ltd. had annual revenue of 915.32M with 4.82% growth.
- Revenue (ttm)
- 867.63M
- Revenue Growth
- -3.09%
- P/S Ratio
- 1.45
- Revenue/Employee
- TWD 6,400,846
- Employees
- 143
- Market Cap
- TWD 1.33B
Revenue Chart
Greenyn Biotechnology Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 915.32M | 42.08M | 4.82% |
| Dec 31, 2024 | 873.24M | 72.73M | 9.09% |
| Dec 31, 2023 | 800.51M | 95.20M | 13.50% |
| Dec 31, 2022 | 705.31M | 11.54M | 1.66% |
| Sep 30, 2022 | 693.77M | 31.21M | 4.71% |
| Dec 31, 2020 | 662.56M | 78.37M | 13.42% |
| Dec 31, 2019 | 584.19M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.